Eikonoklastes Therapeutics, Inc.
6 private offerings reported to the SEC on Form D since 2016, $27.5M sold in all. Pharma, Ohio.
- Form D offerings: 6
- Reported sold: $27.5M
- Newest: Jul 29, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Jul 29, 2025 | — | $16.1M | $18.6M | Eikonoklastes Therapeutics, Inc.Pharma · Ohio | Oct 6, 2026 | 0001805698-25-000002 |
| Jun 25, 2024 | — | $2.4M | $8.0M | Eikonoklastes Therapeutics, Inc.Pharma · Ohio | Not amended | 0001805698-24-000001 |
| Nov 27, 2023 | — | $2.0M | $15.0M | Eikonoklastes Therapeutics, Inc.Pharma · Ohio | Not amended | 0001805698-23-000001 |
| Jan 13, 2022 | — | $2.8M | $7.0M | Eikonoklastes Therapeutics, Inc.Pharma · Ohio | Not amended | 0001805698-22-000001 |
| May 6, 2021 | — | $3.2M | $7.0M | Eikonoklastes Therapeutics, Inc.Pharma · Ohio | Not amended | 0001805698-21-000002 |
| Mar 5, 2020 | — | $1.1M | $4.0M | Eikonoklastes Therapeutics, Inc.Pharma · Ohio | Not amended | 0001805698-20-000001 |
- Business address
- Cincinnati, Oh
- Incorporated in
- Delaware
- All SEC filings
- CIK 1805698 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR